Comparative effectiveness of abatacept, apremilast, secukinumab and ustekinumab treatment of psoriatic arthritis : a systematic review and network meta-analysis

2018
journal article
article
53
dc.affiliationWydział Nauk o Zdrowiu : Instytut Zdrowia Publicznegopl
dc.cm.date2020-01-07
dc.cm.id86927
dc.contributor.authorKawalec, Paweł - 130055 pl
dc.contributor.authorHolko, P.pl
dc.contributor.authorMoćko, Paweł - 194379 pl
dc.contributor.authorPilc, Andrzej - 133153 pl
dc.date.accessioned2020-01-17T09:20:23Z
dc.date.available2020-01-17T09:20:23Z
dc.date.issued2018pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.number2pl
dc.description.physical189-201pl
dc.description.points20pl
dc.description.versionostateczna wersja wydawcy
dc.description.volume38pl
dc.identifier.doi10.1007/s00296-017-3919-7pl
dc.identifier.eissn1437-160Xpl
dc.identifier.issn0172-8172pl
dc.identifier.projectROD UJ / OPpl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/142235
dc.languageengpl
dc.language.containerengpl
dc.rightsUdzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa*
dc.rights.licenceCC-BY
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/legalcode.pl*
dc.share.typeinne
dc.subtypeArticlepl
dc.titleComparative effectiveness of abatacept, apremilast, secukinumab and ustekinumab treatment of psoriatic arthritis : a systematic review and network meta-analysispl
dc.title.journalRheumatology Internationalpl
dc.typeJournalArticlepl
dspace.entity.typePublication
dc.affiliationpl
Wydział Nauk o Zdrowiu : Instytut Zdrowia Publicznego
dc.cm.date
2020-01-07
dc.cm.id
86927
dc.contributor.authorpl
Kawalec, Paweł - 130055
dc.contributor.authorpl
Holko, P.
dc.contributor.authorpl
Moćko, Paweł - 194379
dc.contributor.authorpl
Pilc, Andrzej - 133153
dc.date.accessioned
2020-01-17T09:20:23Z
dc.date.available
2020-01-17T09:20:23Z
dc.date.issuedpl
2018
dc.date.openaccess
0
dc.description.accesstime
w momencie opublikowania
dc.description.numberpl
2
dc.description.physicalpl
189-201
dc.description.pointspl
20
dc.description.version
ostateczna wersja wydawcy
dc.description.volumepl
38
dc.identifier.doipl
10.1007/s00296-017-3919-7
dc.identifier.eissnpl
1437-160X
dc.identifier.issnpl
0172-8172
dc.identifier.projectpl
ROD UJ / OP
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/142235
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights*
Udzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa
dc.rights.licence
CC-BY
dc.rights.uri*
http://creativecommons.org/licenses/by/4.0/legalcode.pl
dc.share.type
inne
dc.subtypepl
Article
dc.titlepl
Comparative effectiveness of abatacept, apremilast, secukinumab and ustekinumab treatment of psoriatic arthritis : a systematic review and network meta-analysis
dc.title.journalpl
Rheumatology International
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
12
Views per month
Views per city
Ashburn
3
Chandler
2
Des Moines
2
Wroclaw
2
Dublin
1
Downloads
kawalec_et-al_comparative_effectiveness_of_abatacept_apremilast_secukinumab_2018.pdf
26
kawalec_et-al_comparative_effectiveness_of_abatacept_apremilast_secukinumab_2018.odt
4